Note: Ingredients listed on restricted chemical lists
EC/CAS
85-68-7
Name of the chemical
Benzylbutylphthalat
Concentration
5-10%
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
10-30% 10-30%
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
0.1-1%
General Information
Version
1.20
Revision date
2013-09-01
Product name
Sealant
Product name
Sealant
Identification on the label/Trade name
Regulatory Compliance
Chemical name
Sealant
Manufacturer Name
Momentive Performance Materials - Daytona
Emergency telephone
1-800-424-9300, 1-888-443-9466
Icons in SDS
Company Information
company name
Momentive Performance Materials - Daytona
e-mail address of the competent person responsible for the Safety Data Sheet
4information@momentive.com
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW WARNING! Harmful if inhaled, absorbed through skin, or swallowed. May cause skin, eye, and respiratory tract irritation. Do not breathe vapors. Form: Solid Form: White Odor: Ammonia.
Potential health effects
INGESTION Harmful if swallowed. Irritation of the mouth, throat, and stomach. May cause reproductive effects based on results of animal studies. SKIN May be absorbed through the skin and contribute to the symptoms listed under "Ingestion". INHALATION May cause irritation to the mucous membranes and upper respiratory tract. High concentrations of vapors may irritate respiratory system and lead to headache, fatigue, nausea and vomiting. Avoid inhalation of vapors and spray mists. EYES Contact can cause severe irritation and conjunctivitis (redness and swelling).
Medical Conditions Generally Aggravated by Exposure
Persons with pre-existing respiratory tract, skin, lung (such as asthma), and kidney disorders may be aggravated by exposure to this product. SUBCHRONIC (TARGET ORGAN ) Respiratory System; Kidney
Potential chronic health
/ CARCINOGENICITY This product contains stoddard solvent or mineral spirits. Chronic and repeated overexposure may result in adverse liver and kidney effects, bone marrow hyperplasia, and intracerebral hemorrhage.
Principle Routes of Exposure
Dermal; Eye
